Reporting Manager
Poplar Point Capital Management LLC
Symbol
NBY
Shares outstanding
125,962,963 shares
Disclosed Ownership
1,020,300 shares
Ownership
0.81%
Form type
SCHEDULE 13D/A
Filing time
11 Mar 2026, 13:27:52 UTC
Date of event
20 Oct 2025
Previous filing
17 Oct 2025

Quoteable Key Fact

"POPLAR POINT CAPITAL MANAGEMENT LLC disclosed 0.81% ownership in Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY) on 20 Oct 2025."

Quick Takeaways

  • POPLAR POINT CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY).
  • Disclosed ownership: 0.81%.
  • Date of event: 20 Oct 2025.

What Changed

  • Previous schedule filing date: 17 Oct 2025.
  • Current filing was accepted on 11 Mar 2026, 13:27.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Poplar Point Capital Management LLC 0.81% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588273
Poplar Point Capital Partners LP 0.81% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588289
Poplar Point Capital GP LLC 0.81% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588288
Jad Fakhry 0.81% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry 0001588217
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .